Compare NWTG & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NWTG | CPHI |
|---|---|---|
| Founded | 2018 | N/A |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3M | 6.5M |
| IPO Year | N/A | N/A |
| Metric | NWTG | CPHI |
|---|---|---|
| Price | $1.62 | $1.32 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 46.6K | ★ 50.5K |
| Earning Date | 11-13-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $6,931,000.00 | $4,052,266.00 |
| Revenue This Year | $120.41 | N/A |
| Revenue Next Year | $70.24 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 178.24 | N/A |
| 52 Week Low | $0.82 | $1.18 |
| 52 Week High | $40.20 | $3.35 |
| Indicator | NWTG | CPHI |
|---|---|---|
| Relative Strength Index (RSI) | 54.16 | 48.89 |
| Support Level | $1.49 | $1.19 |
| Resistance Level | $1.64 | $1.35 |
| Average True Range (ATR) | 0.13 | 0.09 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 61.43 | 40.00 |
Newton Golf Co Inc is a technology-forward golf company dedicated to revolutionizing the sport with cutting-edge, high-performance products. The company's expanding portfolio includes golf shafts, putters, grips, and other golf-related accessories designed for golfers of all skill levels. The company sells its products through e-commerce, distributors, wholesale customers, including pro-shops at golf courses and off-course retailers, sporting goods retailers, online retailers, third-party distributors, and through Club Champion Golf, as well as through mass merchants and corporate customers in the Americas, Asia, and Europe.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.